Ustekinumab-Ttwe 68225-0251-00
- Manufacturer
- Patheon Italia S.p.a
- Dosage Form
- Injection, Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- February 22, 2025
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Ustekinumab | 90 mg/mL |
Selected Package
68225-0251-00Selected2400 SYRINGE, GLASS in 1 BOX (68225-251-00) / 1 mL in 1 SYRINGE, GLASS